📰 Full Story
Jardine Matheson said on May 25 it will acquire Australia’s I-MED Radiology Network for an enterprise value of A$3.4 billion (about $2.4 billion), buying a 100% stake from funds advised by private equity firm Permira and other shareholders.
The purchase includes I-MED’s minority holding in AI developer Harrison.ai.
Jardines said the deal will be funded through cash reserves and debt financing, is expected to be neutral to underlying earnings per share in the first full year after closing and accretive thereafter, and is subject to regulatory approvals with completion expected later in 2026.
I-MED operates roughly 215 diagnostic imaging clinics across Australia and New Zealand, performs more than seven million procedures annually, and provides teleradiology services in Australia, New Zealand and the United States.
Jardines’ chief executive Lincoln Pan described the acquisition as aligned with a strategy to invest in market-leading, growth businesses.
The deal values I-MED at about 11.5 times forecast adjusted EBITDA for the year ending June 2026 (excluding the Harrison.ai stake).





💬 Commentary